Miyauchi, Akimitsu
Hamaya, Etsuro
Shimauchi, Junichiro
Yoshinaga, Yoko
Nishi, Kiyoshi
Funding for this research was provided by:
Amgen
Astellas Pharma
UCB Pharma
Article History
Received: 29 June 2023
Accepted: 25 October 2023
First Online: 12 December 2023
Declarations
:
: Akimitsu Miyauchi has received consulting fees from Amgen and Teijin Pharma. Etsuro Hamaya and Kiyoshi Nishi are employees and stockholders of Amgen. Junichiro Shimauchi is an employee of Amgen. Yoko Yoshinaga is a former employee of Amgen.